Catumaxomab
DB06607
Approved Indication
Investigated for use/treatment in gastric cancer, ovarian cancer, and cancer/tumors (unspecified).
0
Targets
0
Resistance Mutations
0
References
3D Structure
No structure available
No co-crystal structure available
Protein Targets
Mechanism of Action
Not available.
Details
DrugBank ID
DB06607 ↗
Approval Date
—
Molecular Weight
— g/mol
Drug Class
Other
ATC Codes
L01XC09
Synonyms
—